Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|January 4, 2021

Global Virtual Clinical Trials Market Industry Analysis and Forecast Report Released

Reportlinker.com has announced the release of the report "Global Virtual Clinical Trials Market By Study Type, By Indication, By Region, Industry Analysis and Forecast, 2020 – 2026."

The market is significantly driven by growth in R&D activities, the growing digitization in healthcare, and the adoption of telehealth. Virtual Clinical Trials or remote/decentralized trails are a relatively new but still underused technique of carrying out clinical research taking complete benefit of technologies like apps, online social interaction platforms, and electronic monitoring tools. Advances in technology, collaborations between clinical research companies, biotechnology companies, and pharmaceutical and support initiatives from governments, are expected to boost the market. The market’s size is expected to reach $10 billion by 2026, rising at a market growth of 6. 5% CAGR during the forecast period.

For more of report’s analysis, click here.


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.